WECOME(300878.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
WECOME
300878.SZ
Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd.
2.805 T
300878.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking194/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-20.95%E
    • Profit Margin-95.82%E
    • Gross Margin59.50%A
  • Growth ScoreD
    • Revenue YoY1.87%C
    • Net Profit YoY-18.79%D
    • Total Assets YoY-21.43%E
    • Net Assets YoY-20.46%E
  • Cash ScoreD
    • Cash Flow Margin-24.42%E
    • OCF YoY1.87%C
  • Operating ScoreD
    • Turnover0.15D
  • Debt ScoreB
    • Gearing Ratio28.11%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suit

    Wallstreetcn·
    SZ
    300878
    +2.92%
    SH
    688221
    +1.44%
    SH
    600513
    -1.07%
    Wallstreetcn·
    SZ
    300878
    +2.92%
    SH
    688221
    +1.44%
    SH
    600513
    -1.07%

    A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suit

    Zhitong·
    SZ
    300878
    +2.92%
    SZ
    300497
    -0.61%
    SZ
    002940
    -5.31%
    Zhitong·
    SZ
    300878
    +2.92%
    SZ
    300497
    -0.61%
    SZ
    002940
    -5.31%

    WECOME Pharmaceuticals released its performance for the first three quarters, with a net loss attributable to the parent company of 124 million yuan

    Zhitong·
    SZ
    300878
    +2.92%
    Zhitong·
    SZ
    300878
    +2.92%

    The A-share chain pharmacy IPO project is here: Kangbaijia starts counseling

    Wallstreetcn·
    SZ
    300878
    +2.92%
    Wallstreetcn·
    SZ
    300878
    +2.92%

    The Zhejiang Securities Regulatory Bureau has issued warning letters to Minsheng Securities, Ren Shaozhong, and Zhong Desong

    Zhitong·
    SZ
    300878
    +2.92%
    Zhitong·
    SZ
    300878
    +2.92%
    © 2026 Longbridge｜Disclaimer